Structural Mechanism of an Efficacy Photoswitch Targeting the β 2 ‐adrenergic Receptor

ABSTRACT The field of photopharmacology develops light‐responsive drugs that can modulate protein activity, enabling precise and dynamic investigations of their roles in health and disease. Adrenergic receptors are prominent targets for this approach because they are prototypical G protein‐coupled receptors with high clinical relevance in bronchial and cardiovascular diseases. Here, we employed the azobenzene‐based compound photoazolol‐1 in combination with time‐resolved serial crystallography at X‐ray free‐electron lasers to resolve the molecular mechanisms by which photoswitchable β‐blockers modulate activity of the β 2 ‐adrenoceptor (β 2 AR). Time‐resolved structures of the receptor bound to trans ‐photoazolol‐1 (pre‐photoconversion), a strained intermediate in the nanosecond range, and the fully photoisomerized cis ‐photoazolol‐1 reveal how isomerization of the azobenzene moiety induces distinct conformational changes within the orthosteric ligand binding pocket. Within seconds, light‐excited photoazolol‐1 adopts a new binding pose, altering interactions with extracellular loop 2 and shifting the positions of transmembrane helices 5, 6, and 7. Functional assays of β 2 AR in cellular membranes show that photoazolol‐1 acts as an efficacy photoswitch, changing from an inverse agonist to a neutral antagonist upon isomerization without leaving the binding pocket. In combination, these findings suggest a molecular mechanism for activity modulation via efficacy photoswitches and provide a framework for designing ligands that exploit light‐driven transitions within the binding pocket to achieve spatiotemporal control of receptor function.